Revance Therapeutics Inc (RVNC)
2.83
-0.06
(-2.08%)
USD |
NASDAQ |
May 31, 16:00
2.83
0.00 (0.00%)
After-Hours: 20:00
Revance Therapeutics Price: 2.83 for May 31, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 31, 2024 | 2.89 | 3.00 | 2.81 | 2.83 | 1.696M |
| May 30, 2024 | 2.84 | 2.94 | 2.77 | 2.89 | 1.821M |
| May 29, 2024 | 2.68 | 2.84 | 2.605 | 2.80 | 2.412M |
| May 28, 2024 | 2.71 | 2.769 | 2.59 | 2.67 | 1.811M |
| May 24, 2024 | 2.70 | 2.76 | 2.63 | 2.71 | 1.518M |
| May 23, 2024 | 2.95 | 2.955 | 2.625 | 2.67 | 3.000M |
| May 22, 2024 | 3.01 | 3.12 | 2.92 | 2.92 | 1.920M |
| May 21, 2024 | 3.13 | 3.159 | 2.98 | 3.01 | 1.885M |
| May 20, 2024 | 3.04 | 3.18 | 2.90 | 3.16 | 2.472M |
| May 17, 2024 | 3.18 | 3.205 | 3.02 | 3.02 | 2.197M |
| May 16, 2024 | 3.31 | 3.35 | 3.11 | 3.16 | 2.416M |
| May 15, 2024 | 3.58 | 3.65 | 3.27 | 3.31 | 2.560M |
| May 14, 2024 | 3.43 | 3.555 | 3.37 | 3.48 | 3.962M |
| May 13, 2024 | 3.40 | 3.60 | 3.225 | 3.32 | 2.852M |
| May 10, 2024 | 4.05 | 4.05 | 3.00 | 3.32 | 8.076M |
| May 09, 2024 | 4.31 | 4.475 | 4.250 | 4.29 | 1.465M |
| May 08, 2024 | 4.30 | 4.35 | 4.19 | 4.27 | 1.134M |
| May 07, 2024 | 4.12 | 4.40 | 4.105 | 4.38 | 1.348M |
| May 06, 2024 | 4.00 | 4.11 | 3.925 | 4.10 | 1.144M |
| May 03, 2024 | 3.92 | 4.071 | 3.88 | 3.95 | 1.371M |
| May 02, 2024 | 3.91 | 3.99 | 3.655 | 3.77 | 1.256M |
| May 01, 2024 | 3.75 | 4.058 | 3.65 | 3.795 | 1.961M |
| Apr 30, 2024 | 3.63 | 3.785 | 3.510 | 3.61 | 2.111M |
| Apr 29, 2024 | 3.45 | 3.77 | 3.41 | 3.69 | 3.224M |
| Apr 26, 2024 | 3.36 | 3.56 | 3.21 | 3.40 | 2.280M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.67
Minimum
May 23 2024
37.61
Maximum
May 09 2023
19.87
Average
20.30
Median
Nov 09 2022
Price Benchmarks
| AbbVie Inc | 161.24 |
| Design Therapeutics Inc | 4.05 |
| Humacyte Inc | 7.47 |
| Context Therapeutics Inc | 1.98 |
| AN2 Therapeutics Inc | 1.99 |
Price Related Metrics
| PS Ratio | 1.044 |
| Earnings Yield | -128.6% |
| Market Cap | 295.59M |